Pharma fights during a pandemic.
Seven million Americans have lost their health insurance under the Trump Administration.
Mallinckrodt Pharmaceuticals announced today that the company expects to pay $15.4 million in a settlement with the U.S. Justice Department.
A prominent disability rights activist and attorney died this past Sunday after being refused an essential medication by her insurance company.
From the reddest of red states to the bluest of blue, there is one unifying chorus that echoes across the United States: Prescription drug prices are too high.
Macroeconomic pressures have hit the R&D returns of life sciences firms.